Etsy Inc (ETSY) Stock Price Today
Aura AI Summary
Key Stats
- $6.76BMarket Cap
- 3,935,292Volume
- Consumer CyclicalSector
- $87.0352W High
- $44.0552W Low
- 67 DaysTypical Hold Time
- $8.72BEnterprise Value
- -Div Yield
- 0% Sell | 100% BuyTrading Activity
Track Etsy Inc (ETSY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Etsy Inc has traded between a low of $44.05 and a high of $87.03, highlighting its annual price range. Buy and sell Etsy Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Most Recent News
General Mills sees 3% sales drop but beats earnings estimates with strong international growth.
General Mills reported a 3% decline in sales to $4.40 billion, partly due to selling its U.S. yogurt business, causing adjusted gross margin to fall to 33.3%. Despite this, the company beat earnings expectations with adjusted EPS of $0.75, helped by ...
Replimune faces securities lawsuit over alleged misleading FDA trial data claims on RP1 drug resubmission.
Investors have filed a securities class action against Replimune Group, alleging the company misled the market by claiming its RP1 drug resubmission fully addressed FDA concerns, despite the FDA stating the trial data was inadequate. The lawsuit high...
Oracle stock drops 6% after force majeure notice on New Mexico data center project delays
Oracle's stock fell nearly 6% after the company issued a force majeure notice regarding its New Mexico data center, Project Jupiter. The notice aims to protect Oracle from higher costs and delay payments if the facility, part of a major AI infrastruc...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.